期刊文献+

辅酶Q10纳米乳剂的研制及经皮性能考察

Preparation and transdermal properties study of coenzyme Q10 nanoemulsion
下载PDF
导出
摘要 目的制备经皮透过量低,滞留量高的可用于皮肤护理的辅酶Q10(coenzyme Q10,Co-Q10)水包油型纳米乳。方法以滞留比为指标,对以聚乙二醇1000维生素E琥珀酸酯(tocopheryl polyethylene glycol 1000 vitamin E succinate, TPGS)为主要乳化剂的纳米乳进行处方优化,筛选出最佳处方。以日本大耳白兔离体皮肤作为透皮模型,采用立式扩散池,进行离体经皮渗透试验并测定Co-Q10的含量。结果优化后的最终纳米乳处方组成为:中链甘油三酯(medium chain triglycerides, MCT)1 g,甘油3.34 g, TPGS 1.66 g,水4 g, Co-Q10 50 mg。纳米乳粒径为32.2 nm,多分散指数(polydispersity index, PDI)为0.177。折光率为1.336 5,黏度为59.8 mPa·s。测定Co-Q10的8 h的滞留量为37.66μg·cm-2,滞留比为1.93。结论该制剂药物有一定的通过率,滞留比高,适合于局部给药。 Objective To optimize the preparation of coenzyme Q10(Co-Q10) transdermal nanoemulsion with the low skin permeability and the high retention capacity.Methods Using the retention ratio as an indicator, the formulation of nanoemulsion with tocopheryl polyethylene glycol 1000 vitamin E succinate(TPGS) as the main emulsifier was optimized, and the best prescription was screened out.Percutaneous penetration tests were performed with vertical diffusion cells using rabbit skin in vitro to determine the content of Co-Q10.Results The optimized composition of the nanoemulsion was MCT:1 g, glycerol: 3.34 g, TPGS:1.66 g, water: 4 g, and Co-Q10:50 mg.The particle size of nano-emulsion was 32.2 nm with the PDI of 0.177,refractive index of 1.336 5,and the viscosity of 59.8 mPa·s.The 8-hour rabbit skin retention of Co-Q10 was 37.66 μg·cm-2,and the retention ratio was 1.93.Conclusion This optimized prescription has a high retention ratio and is suitable for topical administration.
作者 张子钰 高晴 李文哲 王中彦 ZHANG Ziyu;GAO Qing;LI Wenzhe;WANG Zhongyan(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang 110016,China)
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2021年第7期656-662,共7页 Journal of Shenyang Pharmaceutical University
关键词 辅酶Q10 聚乙二醇1000维生素E琥珀酸酯 水包油型纳米乳 离体经皮渗透试验 coenzyme Q10 tocopheryl polyethylene glycol 1000 vitamin E succinate oil-in-water nanoemulsion percutaneous penetration test in vitro
  • 相关文献

参考文献3

二级参考文献43

  • 1于永新,俞红凯,王中彦.聚乙二醇1000维生素E琥珀酸酯应用进展[J].沈阳药科大学学报,2006,23(6):407-412. 被引量:16
  • 2MU L, FENG SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol) [J]. J Control Release, 2002, 80 ( 1-3 ) : 129-144.
  • 3DINTAMAN JM, SILVERMAN JA. Inhibition of P-glyco-protein by D - c - toeopheryl polyethylene glycol 1000 succinate (TPGS) [J]. Pharm Res, 1999, 16(10): 1550-1556.
  • 4CAO N, FENG SS. Doxorubicin conjugated to D- alpha- tocopheryl polyethylene glycol 1000 suceinate (TPGS) : conjugation chemistry, characterization, in vitro and in vivo evaluation[J]. Biomaterials, 2008, 29(28): 3856-3865.
  • 5ANBHARASI V, CAO N, FENG SS. Doxorubicin conjugated to D-alpha-toeopheryl polyethylene glycol sueeinate and folic acid as a prodrug for targeted chemotherapy[J]. J Biomed Mater Res A, 2010, 94(3): 730-743.
  • 6MI Y, ZHAO J, FENG SS. Vitamin E TPGS prodrug micelles for hydrophilie drug delivery with neuroproteetive effects[J]. Int J Pharm, 2012, 438(1-2): 98-106.
  • 7SADOQI M, LAU- CAM CA, WU SH. Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometry[J]. J Colloid Interface Sci, 2009, 333 (2) : 585-589.
  • 8XU H, ABE H, NAITO M, et all. Efficient dispersing and shortening of super- growth carbon nanotubes by ultrasonic treatment with ceramic balls and surfactants [J]. Adv Powder Technol, 2010, 21(5): 551-555.
  • 9YAN A, yon dem BUSSCHE A, KANE AB, et al. Toeopheryl polyethylene glycol suecinate as a safe, antioxidant surfaetant for processing carbon nanotubes and fullerenes [J]. Carbon N Y,2007, 45(13): 2463-2470.
  • 10CHANDRASEKHARAN P, MAITY D, YONG CX, et al. Vitamin E (D-alpha-tocopheryl-co-poly (ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI[J]. Biomaterials, 2011, 32 (24) : 5663-5672.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部